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whether this holds also true for ß-myosin missense mutations. We have
analyzed 7 different ß-myosin heavy chain mutations in slow skeletal muscle
fibers that also express ß-myosin and in cardiomyocytes. Only one mutation
showed higher calcium-sensitivity (G741R), three had enhanced Fmax
(R719W, R723G, R453C), and two showed increased fiber ATPase (R719W,
R453C). One mutation had even lower force generation and one had reduced
calcium-sensitivity. Samples with mutations V606M and G584R showed no
significant functional alterations.
Our earlier studies, however, showed a surprisingly large variability in pCa50
among individual fibers carrying the same mutation, ranging from almost
normal values to highly significant differences. In control fibers, such large
functional variability was absent. To clarify the reason for this we now quan-
tified the relative abundance of mutated vs. wildtype ß-myosin-mRNA in single
fibers. A highly variable expression of mutated myosin from fiber to fiber was
found that may cause the observed unequal force generation. Currently, relative
myosin expression is also tested in individual FHC-cardiomyocytes.
Our data imply that not all HCM-mutations share a common set of specific
functional effects. Instead, we hypothesize that expression of mutated and wild-
type myosin are unequal in individual cardiomyocytes, leading to imbalanced
force generation among individual myocytes in FHC-patient’s myocardium.
We propose that this allelic imbalance of ß-myosin from cardiomyocyte to car-
diomyocyte triggers functional imbalance, setting off altered cell signaling and
morphology like myofibrillar and myocyte disarray.
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Dilated cardiomyopathy (DCM) is the cause of death for a significant subset of
patients with Marfan syndrome (MFS), a connective tissue disorder involving
the extracellular matrix (ECM) protein fibrillin-1. However, it remains contro-
versial whether this DCM is a primary symptom of MFS or a secondary effect
of the more common vascular and heart valve defects. We trace the multi-scale
mechanical pathway from cardiac chamber function to sub-cellular stiffness
and adhesion in a mutant (MT) mouse model that expresses ~20% of normal
fibrillin-1 and displays early onset and progressively severe symptoms of
MFS. Pressure-volume (PV) loop curves measured in MT mice demonstrate
a rightward shift with significant elevation of end-diastolic and end-systolic
volumes (p < 0.05) compared to wild-type (WT) littermates. Elastic modulus
of isolated whole hearts measured using atomic force microscopy (AFM) indi-
cates significantly softer tissue for MT (5.35 4.0 kPa, n=4) compared to WT
(21.1 5 10.2 kPa, n=4, p < 0.0001). AFM was also utilized to measure sub-
cellular stiffness and surface receptor binding affinity on live cardiomyocytes
isolated from the two mouse models and maintained in a passive state with
blebbistatin. Interestingly, cell stiffness was not different between MT
(2.25 0.6 kPa, n=6) and WT (2.65 0.6 kPa, n=10, p = 0.23), whereas surface
adhesion was diminished significantly in the MT cells (1385 99 pN vs. 5605
268 pN, p = 0.0025). The results imply an ECM-driven maladaptive response of
cardiac function in the MFS model, as evidenced by the decreased whole heart
stiffness while cardiomyocyte passive stiffness remains unaltered. The dimin-
ished cell surface adhesion force suggests impaired myocyte-ECM binding that
is critical for multi-scale force transmission in the heart, revealing a possible
direct biophysical mechanism for the cardiomyopathy observed in Marfan
syndrome.
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In the heart, protein nitrosylation has been described as cardio-protective
against oxidative stress, yet the mechanisms are largely unknown. We hypoth-
esize that direct nitrosylation of myofilament proteins at specific cysteine res-
idues could contribute to this cardio-protective effect. We previously described
how the nitrosonium donor, CysNO, could affect adult cardiac myocyte
contractility by direct nitrosylation of the myofilament regulatory proteins car-
diac troponin I (cTnI) and troponin C (cTnC). In addition, we found that nitro-
sylation of cTnI could affect its phosphorylation at serines 23 and 24. In the
current study, we further examined how nitrosylation could affect myofilament
proteins, focusing on cTnI and cTnC. First, we found endogenous nitrosylatedmyofilament proteins, including troponin I and C, that could be de-nitrosylated
by the addition of ascorbate as a reductant. Using cysteine knockout mutants,
we determined the rate and efficiency of individual cysteine residues to
trans-nitrosation by CysNO. Next, we found that direct nitrosylation of cTnI
and cTnC affected its subsequent protein phosphorylation. Conversely, we
found that a pseudo-phosphorylated cTnI at serines 23 and 24 also affected
its nitrosylation. Finally, direct nitrosylation of myofilament proteins with Cy-
sNO reduced its degradation by H2O2. Together, our results provide evidence
that direct nitrosylation of myofilament proteins is site-specific and could be
protective against oxidative damage.
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The Frank-Starling mechanism, whereby increased cardiac filling leads to
increased cardiac output, is dependent on cardiomyocyte sarcomere length
(Ls). The relationship between Ls and left-ventricular pressure (LVP) in living
(non-fixed)myocardium is poorly defined.We examined theLs versusLVP rela-
tionship in isolated perfused mouse hearts using 2-photon fluorescence micro-
scopy. To determine a fluorescent indicator of Ls, isolated cardiomyocytes
were labeled with Di-8-ANEPPS (membrane dye labeling t-tubules) and Mito-
Tracker DeepRed (mitochondrial stain) and imaged using confocalmicroscopy.
The resulting fluorescence signals were correlated to transmitted light Ls ob-
tained under resting conditions and in the presence of 10 mM caffeine to induce
cellular contracture. Fast-Fourier Transform and linear regression analyses illus-
trated that Di-8-ANEPPS (r2=0.97) and MitoTracker (r2=0.95) were both well-
correlated to transmitted light Ls. Perfused hearts were loaded with Di-8-
ANEPPSwith the left-ventricle cannulated (via the left atrium) to alter LVP. Im-
aging was performed on an inverted microscope with the left-ventricular wall
against the coverglass, allowing sub-epicardial cardiomyocytes to be imaged
while their longitudinal axis was parallel to the focal plane. Measurements
were performed under passive conditions (Ca-free, 25C) with aortic pressure
1 mmHg higher than LVP at each pressure examined. Sarcomere length (mm)
increased with LVP, with values of 2.0250.01 at 0 mmHg, 2.2450.02 at 10
mmHg, 2.2950.02 at 20 mmHg, and 2.3350.02 at 40 mmHg. These values
are consistent with data inmammalian hearts fixed at varyingLVP, and illustrate
that Ls is more dynamic over lower pressure ranges (0-20 mm Hg) than higher
pressure ranges (20-40 mm Hg). We conclude that the Ls-LVP relationship
can be determined accurately in the living heart using 2-photon fluorescence mi-
croscopy, which should prove valuable for investigating disease-associated
changes in passive properties of the heart.
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Active force in cardiac muscle is highly dependent on sarcomere length (SL),
which is known as the Frank-Starling mechanism of the heart. Indeed, a change
of merely ~100 nm in SL causes a dramatic change in cardiac contractile per-
formance under partial activation states, highlighting the need for real-time SL
imaging at high spatial and temporal resolution in vivo. In the present study, we
expressed AcGFP at sarcomeric Z-disks (a-actinin) by means of an adenovirus
vector system in adult mice, and applied nanometry for the measurement of SL
displacement (i.e., SL nanometry) at 100 fps in the myocytes in the center of the
left ventricle in anesthetized open-chest mice under a fluorescence microscope
(combined with a spinning disk confocal unit and an EMCCD camera). First,
we found that SL changed in the lengths of ~1.92 and ~1.63 mm during diastole
and systole, respectively, and varied by ~300 nm in both phases even in the
same myocyte. Second, we found that sarcomere contraction started to occur
at the T-wave endpoint on the electrocardiogram, followed by a rapid increase
in left ventricular pressure (LVP). Similarly a linear relationship existed be-
tween the magnitude of the change in SL and that in LVP, demonstrating for
the first time direct evidence of the Frank-Starling mechanism at the sarcomere
level in vivo. Finally, we reconstructed the Z-sectioning images (at Z = 1 mm)
of single sarcomeres by using the piezoelectric actuator, and successfully
observed sarcomeric motions during the entire cardiac cycle. The present
646a Wednesday, February 19, 2014experimental system has a broad range of application possibilities for unveiling
single sarcomere dynamics during excitation-contraction coupling in cardio-
myocytes in the beating heart in vivo. At the meeting, we will discuss the or-
ganization of sarcomeric contraction in the beating heart in vivo.
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Classical ex vivo experiments suggest that the relaxation of cardiac muscle de-
pends on afterload, with lower afterloads producing faster relaxation (Brutseart
et al Circ Res 1980 47(5):637). These original experiments used protocols in
which the muscle returned to its original length before beginning diastolic
relaxation (black lines, Figure 1). In this experimental mode, reducing afterload
increases the velocity of the muscle when
as returns to its original length (the end
systolic strain rate). In this work, we used
electrically simulated rat trabeculae to
test the hypothesis that the strain rate,
and not the afterload, controls relaxation.
We varied the end-systolic strain rate by
allowing the trabeculae to relengthen by
different amounts at a fixed afterload.
Relaxation was slowest when relengthen-
ing was minimal (gray lines, Figure 1)
and fastest when relengthening was com-
plete (black lines, Figure 1). Preload did
not influence this effect. In summary, our
preliminary data suggest that is the strain
rate at the end of systole, and not the force
that the myocardium develops as it con-
tracts, that controls relaxation.3264-Plat
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Background. Experimentally upregulating compliant titins has been suggested
as a possible therapeutic for lowering pathological diastolic stiffness levels.
However, how increasing titin compliance impacts global cardiac function re-
quires in-depth study.Here we investigate the effect of upregulating compliant
titins on diastolic and systolic function in a novel mouse model that we made
with a genetically altered titin splicing factor. We employed integrative ap-
proaches from intact cardiomyocytes studied with a carbon-fiber force-
measuring system to the left ventricular (LV) chamber studied with
pressure(P)-volume(V) analysis and Doppler echocardiography.
Methods and Results. Compliant titins were upregulated through deletion of
the RNA Recognition Motif of the splicing factor RBM20(Rbm20DRRMmice).
At both cardiomyocyte and LV chamber levels diastolic stiffness was reduced
in heterozygous (þ/-) Rbm20DRRMmice with a further reduction in homozygous
(-/-) mice at only the intact myocyte level. Fibrosis was present in only -/-
Rbm20DRRM hearts. The Frank-Starling Mechanism was reduced in a graded
fashion in Rbm20DRRM mice, at both the cardiomyocyte and LV chamber lev-
els.Exercise tests revealed an increase in exercise capacity in þ/- mice.
Conclusions. Results support that titin is not only important in diastolic but
also in systolic cardiac function. Upregulating compliant titin isoforms reduces
diastolic chamber stiffness due to increased compliance of myocytes but de-
presses systolic cardiac reserve; under conditions of exercise-induced cardiac
stress the beneficial effects on diastolic function dominate. Therapeutic manip-
ulation of the RBM20-based splicing system and careful dosing might be able
to avoid effects on fibrosis and systolic function while improving diastolic
function of heart failure patients.
Platform: Structure, Dynamics, and Allostery in
Drug Target Interactions
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covery and refinement, especially with the increased availability of high-
resolution structural data. Traditionally, these methods represent protein targets
as rigid receptors but proteins are fluid molecules that exist in an inter-
converting ensemble of conformational states. Recently, docking protocols
have trended towards incorporating protein flexibility but effectively and effi-
ciently searching the conformational space available to proteins remains a well-
appreciated computational challenge. To this end, we have developed a method
utilizing CHARMM to incorporate side
chain flexibility within grid-based dock-
ing methods, maintaining efficiency while
allowing the protein and ligand conforma-
tions to be sampled simultaneously. This
is unlike induced-fit docking methods
that search only one conformational
space, either protein or ligand, at a time.
Presented here are results for re-docking
and cross-docking simulations and an
assessment of the benefits of incorpo-
rating flexibility in docking when
compared to traditional rigid methods.
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Cyclic adenosine monophosphate (cAMP)-Protein Kinase A (PKA) signaling
is a fundamental pathway for mediating cellular responses to hormonal stim-
uli. cAMP activates PKA by binding to its regulatory (RIa) subunit. While
steps in the activation phase are well understood, little is known on how
signal desensitization/resetting occurs. We specifically set out to determine
(i) how cAMP-bound to the regulatory subunit is hydrolyzed to return RIa
to the kinase-bound state and (ii) the role of phosphodiesterases in enabling
this important regulatory resetting of the system. We report discovery of a
novel signaling complex of a phosphodiesterase (PDE8) and PKA Regulatory
subunit (RIa) in mammalian cAMP signaling by a combination of amide
hydrogen/deuterium exchange mass spectrometry (HDXMS), peptide arrays
and computational docking. A model of the PDE8A-PKA RIa complex re-
veals the phosphodiesterase active site in close proximity to the cAMP bind-
ing site on the PKA target and highlights a role for substrate channeling in
the PDE-dependent dissociation and hydrolysis of cAMP bound to PKA.
This is the first instance of PDEs directly interacting with a cAMP-
receptor protein in a mammalian system and highlights an entirely new class
of binding partners for RIa. This has major implications for regulation of in-
tensity and duration of the cAMP signal in all cells. Furthermore, this intro-
duces molecular channeling as a new paradigm for macromolecular
assemblies in microdomains and localized stimulus-response cycles in cell
signaling. Our model for molecular channeling are consistent with Fluores-
cence Resonance Energy Transfer- reporter assays for cAMP in cells,
providing a new model for understanding spatial and temporal regulation
of cAMP signaling.
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Human SIRT1, the most studied member of the mammalian family of seven
NADþ-dependent sirtuins, is composed of 747 amino acids with a catalytic
core and extended N- and C-terminal regions. Herein we report the design
and characterization of a human SIRT1 construct (mini-hSIRT1) containing
the minimal structural elements required for lysine deacetylation and cata-
lytic activation by sirtuin-activating compounds (STACs). Crystal structures
of mini-hSIRT1/STAC complexes define the STAC binding site within the
N-terminal domain, revealing key intra-molecular interactions. Site-
directed mutagenesis of full-length human SIRT1 confirmed the importance
of key residues in the STAC-binding domain. This structural information,
together with proton-deuteron exchange mass spectrometry data, suggests
a possible mechanism of STAC-mediated catalytic activation. The definitive
determination of the interface governing the binding of STACs with human
SIRT1 facilitates greater understanding of STAC activation of this enzyme
which holds significant promise as a therapeutic target for multiple human
diseases.
